Title: Clinical Observation on Diyu-Shengbai Tablet to Peripheral Hemogram of Malignant Lymphema after Classial Chemotherapy
Abstract: objective: to observe the affect of Diyu-shengbai tablet to Peripheral hemogram of malignant lymphoma after classical chemotherapy.Methods: 33 cases of invasive non-hodgkin's Lymphoma patients were randomly divided into trial group and control group.17 cases of trial group were treated with the diyu-shengbaipian tablet and CHOP chemothyrapy and 16 cases of control group were treated only with CHOP chemotherapy,observe the difference of peripheral hemogram and the dose of colony-stimulating factor between the two groups.Results:the trial group has the lower bone marrow suppression ratio than the control group,which is 11.76% to 31.25%(χ2=4.467,P 0.05).In trial group,There is no significant differences of peripheral hemogram(WBC,PLT,hemoglobin) before and after treatment(P0.05),while the WBC and HB declined obviously,after treatment in control group(P0.05).The dose of colony-stimulating factor used in trial group was fewer than in control group,which is 1.99± 0.58 to 3.62 ± 1.93,(t=2.561,P0.05).Conclusion: diyu-shengbaipian tablets can prevent the bone marrow suppression after chemotherapy of malignant lymphoma,improve WBC and PLT level,and reduce the dosage of colony-stimulating factor,and is worth of popularizing.
Publication Year: 2010
Publication Date: 2010-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot